IBC Policies and Procedures
Below, find the current IBC Policies and Procedures, or download a copy of the IBC Policies and Procedures Document.
Section 1: Introduction
Section 2: Responsibilities
Section 3: Protocol/Modification Submission and Review
Section 4: Meeting Process
Section 5: Reporting Requirements
Section 6: Non-Compliance
Section 7: Training
Section 8: Occupational Health Services Program - Laboratory Animals and Biomedical Services (OHPLABS)
Section 9: Record Retention Policy at The University of Texas at Austin
Questions?
Send all IBC-related matters to the Biosafety Compliance office.
IBC@austin.utexas.edu
512-471-8871
IBC Protocol Review Process and Meeting Dates
Protocols undergo a pre-review that includes an assessment for completeness and confirmation of content before being sent to the committee for review. Once a protocol is complete and pre-review questions have been answered, it is scheduled on a committee agenda.
Complex protocols such as those describing multiple aims, RG-2 vectors, pathogenic agents or novel procedures and technology should be submitted at least four weeks prior to the next committee meeting. Researchers are encouraged to split complex projects, especially those with multiple aims, into additional protocol(s) to facilitate a faster review process.
If funding is pending IBC approval, email IBC@austin.utexas.edu. IBC personnel will help facilitate the protocol submission, review and approval process.
Meetings held may be open to the public, when consistent with protection of privacy and proprietary interests. Please email IBC@austin.utexas.edu at least two weeks in advance to facilitate arrangements.
Meeting Dates
At the discretion of the IBC, scheduled meeting dates may change or additional meeting dates may be added to the schedule.
Scheduled IBC Meeting Dates | Submission Date |
---|---|
January 28, 2025 | January 7, 2025 |
March 4, 2025 | February 12, 2025 |
April 8, 2025 | March 18, 2025 |
May 13, 2025 | April 22, 2025 |
June 10, 2025 | May 20, 2025 |
July 29, 2025 | July 8, 2025 |
September 9, 2025 | August 19, 2025 |
October 14, 2025 | September 23, 2025 |
November 11, 2025 | October 21, 2025 |
December 9, 2025 | November 18, 2025 |
IBC Fees
IBC issues fees for protocol review, amendment and closure. These fees should be considered when writing proposals. Fees are assessed in the following situations:
- Industry sponsored clinical trials submitted for review and approval by the IBC
- Research requiring IBC approval conducted in UT facilities on behalf of non-UT institutions when there is no award to UT
IBC Action | Fee |
---|---|
Initial Convened IBC Review | $2,500 |
Tri-Annual Renewal Review | $2,500 |
Amendment Review | $700 |
Closure | $100 |
IBC Minutes
This is a new requirement starting June 1, 2025
According to the NIH memo Implementation Update: Promoting Maximal Transparency Under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, starting June 1, 2025, the NIH expects that approved meeting minutes from all IBC meetings occurring on, or after this date will be posted publicly on an institutional website. It is NIH's expectation that minutes will be posted immediately after approval and once all appropriate and allowable redactions have been made. Please note that the provisions of this memo only apply to meetings taking place on, or after June 1, 2025. Minutes from meetings before that date do not need to be posted but still must be provided to members of the public upon request.
- June 10, 2025
- July 29, 2025
- September 9, 2025
- October 14, 2025
- November 11, 2025
- December 9, 2025
IBC Contacts
Questions?
Send all IBC-related matters to the Biosafety Compliance office.
IBC@austin.utexas.edu
512-471-8871
Ryan Gray, Ph.D.
IBC Chair, College of Natural Sciences
ryan.gray@austin.utexas.edu
Enamul Huq, Ph.D.
IBC Vice-Chair, College of Natural Sciences
huq@austin.utexas.edu